Showing results (1311-1320 of 2,667) with videos related to
Sort By:
Pageof 267
Frontiers in Microbiology|February 11, 2022
Gastrointestinal Stability and Cytotoxicity of Bacteriocins From Gram-Positive and Gram-Negative Bacteria: A Comparative <i>in vitro</i> StudySamira Soltani, Séverine Zirah, Sylvie Rebuffat, et al.Genes & Development|March 26, 2003
Tpit determines alternate fates during pituitary cell differentiationAnne-Marie Pulichino, Sophie Vallette-Kasic, Judy Peih-Ying Tsai, et al.Journal of Clinical Lipidology|October 16, 2018
The spectrum of type III hyperlipoproteinemiaAllan D Sniderman, Jacqueline de Graaf, George Thanassoulis, et al.European Journal of Cell Biology|May 10, 2017
Macrocyclization of a potent PACE4 inhibitor: Benefits and limitationsTeresa Łepek, Anna Kwiatkowska, Frédéric Couture, et al.The EMBO Journal|June 3, 2000
A novel two-over-two alpha-helical sandwich fold is characteristic of the truncated hemoglobin familyA Pesce, M Couture, S Dewilde, et al.Pharmacological Research|December 14, 2011
Metabolic syndrome potentiates the cardiac action potential-prolonging action of drugs: a possible 'anti-proarrhythmic' role for amlodipineBertrand Caillier, Sylvie Pilote, Dany Patoine, et al.The Journal of Nervous and Mental Disease|February 8, 2006
Do baseline client characteristics predict the therapeutic alliance in the treatment of schizophrenia?Shannon M Couture, David L Roberts, David L Penn, et al.Journal of Molecular Endocrinology|June 1, 1995
Influence of promoter and signal peptide on the expression and secretion of recombinant porcine LH extracellular domain in baculovirus/lepidopteran cells or the caterpillar systemV Bozon, J J Remy, E Pajot-Augy, et al.Atherosclerosis|March 17, 2004
Lack of evidence for reduced plasma apo B48 catabolism in patients with heterozygous familial hypercholesterolemia carrying the same null LDL receptor gene mutationAndré J Tremblay, Benoît Lamarche, Isabelle Ruel, et al.The Journal of Clinical Investigation|January 1, 1995
Crucial residues in the carboxy-terminal end of C1 inhibitor revealed by pathogenic mutants impaired in secretion or functionE Verpy, E Couture-Tosi, E Eldering, et al.Pageof 267